HealthDay.com
Remotely Delivered Behavioral Intervention Reduces Systolic BP Variation
Improvement seen in average systolic BP coefficient of variance and in other variability metrics
Infections From Flesh-Eating Bacteria Are Spreading to New Areas
By Deanna Neff HealthDay Reporter
THURSDAY, Aug. 21, 2025 (HealthDay News) — Health experts across the country are issuing warnings about a surge in infections...
CDC to Lay Off Hundreds in Restructuring
By Deanna Neff HealthDay Reporter
THURSDAY, Aug. 21, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) is finalizing the termination...
California Resident Infected With Plague, Likely from Flea at Lake Tahoe
By Deanna Neff HealthDay Reporter
THURSDAY, Aug. 21, 2025 (HealthDay News) — A resident of South Lake Tahoe, California, has been diagnosed with the plague,...
Molgramostim Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
Once-daily inhaled molgramostim leads to greater increase in pulmonary gas transfer than placebo
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
TAR-200 monotherapy was well tolerated, with high complete response rate and prolonged disease-free survival
Mothers of Children With Down Syndrome Report Need for Improved Screening Communications
Many report navigating the screening process without sufficient information or emotional support
Worse Emotional Health-Related QoL Seen for Women With Cirrhosis, Ascites
More women than men feel depressed, with lower mental component scores seen on the Short Form 36
Metabolic Syndrome Linked to Increased Risk for Parkinson Disease
Highest risk for Parkinson disease seen for participants with metabolic syndrome and high PD-related polygenic risk score
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
Papzimeos is the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis
